Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-04-16 @ 6:17 AM
Study NCT ID:
NCT05495295
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2022-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
Sponsor:
Phost'In Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-27
First Submit QC Date:
None
Study First Post Date:
2022-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-07
Last Update Post Date:
2025-04-08
Last Update Post Date Type:
ACTUAL